These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1746507)
61. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone. Strain EC; Preston KL; Liebson IA; Bigelow GE J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176 [TBL] [Abstract][Full Text] [Related]
62. [Establishment of tree shrew chronic morphine dependent model]. Sun YM; Yang JZ; Sun HY; Ma YY; Wang JH Dongwuxue Yanjiu; 2012 Feb; 33(1):14-8. PubMed ID: 22345003 [TBL] [Abstract][Full Text] [Related]
63. Buprenorphine in cancer pain. Davis MP Support Care Cancer; 2005 Nov; 13(11):878-87. PubMed ID: 16010532 [TBL] [Abstract][Full Text] [Related]
64. Nalbuphine. Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929 [TBL] [Abstract][Full Text] [Related]
65. [The benefit of combining spinal morphine and intravenous buprenorphine for perioperative pain]. Ben-Abraham R; Beltrutti D; Niv D; Weinbroum A Harefuah; 2001 Aug; 140(8):709-12, 806. PubMed ID: 11547472 [TBL] [Abstract][Full Text] [Related]
66. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Azar MR; Jones BC; Schulteis G Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156 [TBL] [Abstract][Full Text] [Related]
67. Opioid-induced respiratory effects: new data on buprenorphine. Dahan A Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215 [TBL] [Abstract][Full Text] [Related]
68. Opioid agonist-antagonist drugs in acute and chronic pain states. Hoskin PJ; Hanks GW Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441 [TBL] [Abstract][Full Text] [Related]
69. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates. Ding H; Czoty PW; Kiguchi N; Cami-Kobeci G; Sukhtankar DD; Nader MA; Husbands SM; Ko MC Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5511-8. PubMed ID: 27573832 [TBL] [Abstract][Full Text] [Related]
70. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects. Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302 [TBL] [Abstract][Full Text] [Related]
71. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Stinus L; Cador M; Zorrilla EP; Koob GF Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444 [TBL] [Abstract][Full Text] [Related]
72. Less pain, more gain: buprenorphine-naloxone and patient retention in treatment. Renzelli CM; Capretto NA J Addict Dis; 2006; 25(3):97-104. PubMed ID: 16956874 [TBL] [Abstract][Full Text] [Related]
73. Therapeutic switch to buprenorphine/naloxone from buprenorphine alone: clinical experience in an Italian addiction centre. Montesano F; Zaccone D; Battaglia E; Genco F; Mellace V Clin Drug Investig; 2010; 30 Suppl 1():13-9. PubMed ID: 20450241 [TBL] [Abstract][Full Text] [Related]
74. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Gades NM; Danneman PJ; Wixson SK; Tolley EA Contemp Top Lab Anim Sci; 2000 Mar; 39(2):8-13. PubMed ID: 11487232 [TBL] [Abstract][Full Text] [Related]
76. The effects of oral morphine and buprenorphine on autotomy following brachial nerve sections in rat. Yamamoto T; Mizuguchi T Pain; 1991 Dec; 47(3):353-358. PubMed ID: 1784506 [TBL] [Abstract][Full Text] [Related]
77. [Treatment of postoperative pain with intravenous PCA system. Comparison with morphine, metamizole, and buprenorphine]. Torres LM; Collado F; Almarcha JM; Huertas VG; de Antonio P; Rodríguez M Rev Esp Anestesiol Reanim; 1993; 40(4):181-4. PubMed ID: 8372257 [TBL] [Abstract][Full Text] [Related]
78. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis. Sinchaisuk S; Ho IK; Rockhold RW Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173 [TBL] [Abstract][Full Text] [Related]
79. Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine. Webster L; Gruener D; Kirby T; Xiang Q; Tzanis E; Finn A Pain Med; 2016 May; 17(5):899-907. PubMed ID: 26917621 [TBL] [Abstract][Full Text] [Related]